SCHEMBL23748649

SCHEMBL23748649

CC/C=C\CCCCOc1cccc(C(=O)O)c1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
CYP3A4 P08684 2/20 0.44
NR1I2 O75469 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
MAPT P10636 1/20 0.44
OPRK1 P41145 1/20 0.44
HTR2B P41595 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
PTGER1 P34995 1/20 0.42
ALDH1A1 P00352 3/20 0.42
PTK2B Q14289 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PGR P06401 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28612051 1.00 KMT2A (0.44) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL28620825 0.92 ALDH1A1 (0.44) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL23748684 0.92 ALDH1A1 (0.44) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL28614075 0.87 MAPT (0.44) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL23748692 0.87 MAPT (0.44) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL25289272 0.84 ALDH1A1 (0.53) KMT2ACYP3A4NR1I2MEN1LMNA
SCHEMBL23748712 0.83 PTGER1 (0.46) KMT2AMEN1PTGER1ALDH1A1PTK2B
SCHEMBL23748646 0.83 PTGER1 (0.46) KMT2AMEN1PTGER1ALDH1A1PTK2B
Orziloben SCHEMBL6531935 0.83 MEN1 (0.57) KMT2ACYP3A4NR1I2MEN1LMNA
Orziloben SCHEMBL23748623 0.82 MEN1 (0.56) KMT2ACYP3A4NR1I2MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-12-09 US disclosed
EP-3864001-A1 ROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF BASF AS (NO) 2021-08-18 EP disclosed
CN-113166024-A Aromatic compounds and their medical use 巴斯夫股份公司 2021-07-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380521-A1 AROMATIC COMPOUNDS AND PHARMACEUTICAL USES THEREOF GLS2, FFAR3, SLC10A1 KMT2A 2026/4885CYP3A4 132/4885NR1I2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.